News
Straumann Group erzielt einen Umsatz von über CHF 2 Milliarden
Straumann Group erzielt einen Umsatz von über CHF 2 Milliarden
Straumann Group reports revenue exceeding CHF 2 billion
Straumann Group reports revenue exceeding CHF 2 billion
MD Medical Group Investments Plc: MD Medical Group launched a new hospital Tyumen-2
MD Medical Group Investments Plc: MD Medical Group launched a new hospital Tyumen-2
Edison Investment Research Limited: Oryzon Genomics (ORY): Planning iadademstat's path to market
Edison Investment Research Limited: Oryzon Genomics (ORY): Planning iadademstat's path to market
DGAP-News: Eckert & Ziegler liefert Lutetium-177 für klinische Studien von Telix
DGAP-News: Eckert & Ziegler liefert Lutetium-177 für klinische Studien von Telix
DGAP-News: Eckert & Ziegler to Supply Telix with Lutetium-177 for Clinical Trials
DGAP-News: Eckert & Ziegler to Supply Telix with Lutetium-177 for Clinical Trials
DGAP-News: Abivax veranstaltet am 17. Februar 2022 ein Satellite Symposium auf dem 17. Kongress der European Crohn's and Colitis Organisation (ECCO)
DGAP-News: Abivax veranstaltet am 17. Februar 2022 ein Satellite Symposium auf dem 17. Kongress der European Crohn's and Colitis Organisation (ECCO)
DGAP-News: Abivax to host Satellite Symposium at the 17th Congress of ECCO on Feb. 17, 2022
DGAP-News: Abivax to host Satellite Symposium at the 17th Congress of ECCO on Feb. 17, 2022
DGAP-News: BRAIN Biotech und Formo: Strategische Kooperation europäischer Biotech-Experten für tierfreie Produktion von Milchproteinen
DGAP-News: BRAIN Biotech und Formo: Strategische Kooperation europäischer Biotech-Experten für tierfreie Produktion von Milchproteinen
DGAP-News: BRAIN Biotech and Formo: Strategic partnership of European biotech experts for the production of animal-free milk protein
DGAP-News: BRAIN Biotech and Formo: Strategic partnership of European biotech experts for the production of animal-free milk protein
Evolva appoints Christian Wichert as new CEO to boost growth strategy and enter its next phase of development and commercialization
Evolva appoints Christian Wichert as new CEO to boost growth strategy and enter its next phase of development and commercialization
EQS-Adhoc: Relief Files Trademark Application for RLF-100 With the U.S. Patent and Trademark Office
EQS-Adhoc: Relief Files Trademark Application for RLF-100 With the U.S. Patent and Trademark Office
MD Medical Group Investments Plc: MDMG reports growth in Revenue 32% in FY 2021
MD Medical Group Investments Plc: MDMG reports growth in Revenue 32% in FY 2021
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Einladung: Straumann Group Webcast - Jahresergebnisse 2021
Einladung: Straumann Group Webcast - Jahresergebnisse 2021
Invitation: Straumann Group 2021 full-year financial results webcast
Invitation: Straumann Group 2021 full-year financial results webcast
Cassiopea gibt Antrag auf Dekotierung ihrer Namenaktien an der SIX Swiss Exchange bekannt
Cassiopea gibt Antrag auf Dekotierung ihrer Namenaktien an der SIX Swiss Exchange bekannt
Cassiopea announces filing for delisting of its registered shares from SIX Swiss Exchange
Cassiopea announces filing for delisting of its registered shares from SIX Swiss Exchange
Kuros Biosciences's MagnetOs Granules cleared by FDA for expanded spinal indications
Kuros Biosciences's MagnetOs Granules cleared by FDA for expanded spinal indications
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
EQS-News: Relief Therapeutics Expands Its Board of Directors with the Appointment of Michelle Lock
EQS-News: Relief Therapeutics Expands Its Board of Directors with the Appointment of Michelle Lock
DGAP-News: BRAIN-Gruppe erweitert ihr Geschäft mit Lebensmittelenzymen durch die Übernahme von Breatec B.V. inklusive der Comix-Aktivitäten
DGAP-News: BRAIN-Gruppe erweitert ihr Geschäft mit Lebensmittelenzymen durch die Übernahme von Breatec B.V. inklusive der Comix-Aktivitäten
DGAP-News: BRAIN Group significantly expands its food enzyme business with the acquisition of Breatec B.V. and Comix business
DGAP-News: BRAIN Group significantly expands its food enzyme business with the acquisition of Breatec B.V. and Comix business
DGAP-News: Burcon NutraScience Corp.: Burcon Announces Fiscal 2022 Third Quarter Conference Call to be Held on February 14, 2022
DGAP-News: Burcon NutraScience Corp.: Burcon Announces Fiscal 2022 Third Quarter Conference Call to be Held on February 14, 2022
DGAP-News: Burcon NutraScience Corp.: Burcon kündigt für 14. Februar 2022 Konferenzgespräch über drittes Quartal 2022 an
DGAP-News: Burcon NutraScience Corp.: Burcon kündigt für 14. Februar 2022 Konferenzgespräch über drittes Quartal 2022 an